Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Glucose | 10 | 2026 | 502 | 1.600 |
Why?
|
| Diabetes Mellitus | 6 | 2026 | 555 | 1.250 |
Why?
|
| Hypoglycemic Agents | 4 | 2019 | 225 | 1.120 |
Why?
|
| Insulin | 6 | 2019 | 696 | 1.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 733 | 0.860 |
Why?
|
| Obesity | 4 | 2015 | 1277 | 0.740 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2019 | 630 | 0.680 |
Why?
|
| Hypoglycemia | 3 | 2019 | 64 | 0.660 |
Why?
|
| Endocrinologists | 1 | 2016 | 5 | 0.500 |
Why?
|
| Physician's Role | 1 | 2016 | 122 | 0.460 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 32 | 0.450 |
Why?
|
| Bariatric Surgery | 2 | 2015 | 65 | 0.440 |
Why?
|
| Gastric Bypass | 2 | 2015 | 69 | 0.420 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 155 | 0.400 |
Why?
|
| Point-of-Care Systems | 2 | 2026 | 137 | 0.390 |
Why?
|
| Adipocytes | 2 | 2015 | 275 | 0.390 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 129 | 0.380 |
Why?
|
| Motor Activity | 1 | 2015 | 346 | 0.370 |
Why?
|
| Energy Metabolism | 1 | 2015 | 400 | 0.360 |
Why?
|
| Prediabetic State | 1 | 2012 | 54 | 0.340 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2024 | 62 | 0.340 |
Why?
|
| Hyperglycemia | 2 | 2026 | 109 | 0.260 |
Why?
|
| Mentoring | 1 | 2026 | 64 | 0.220 |
Why?
|
| Pharmacists | 1 | 2026 | 131 | 0.210 |
Why?
|
| Humans | 21 | 2026 | 65645 | 0.210 |
Why?
|
| Radiation Oncology | 1 | 2024 | 53 | 0.200 |
Why?
|
| Self-Management | 1 | 2024 | 72 | 0.200 |
Why?
|
| Weight Loss | 3 | 2015 | 275 | 0.190 |
Why?
|
| Reproducibility of Results | 4 | 2026 | 1715 | 0.180 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 97 | 0.180 |
Why?
|
| Intensive Care Units | 1 | 2026 | 436 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 593 | 0.180 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 489 | 0.160 |
Why?
|
| Adipose Tissue | 2 | 2014 | 301 | 0.160 |
Why?
|
| Male | 11 | 2026 | 31292 | 0.150 |
Why?
|
| Patient Satisfaction | 2 | 2024 | 442 | 0.140 |
Why?
|
| Female | 11 | 2026 | 34309 | 0.140 |
Why?
|
| Unified Medical Language System | 1 | 2018 | 6 | 0.140 |
Why?
|
| PubMed | 1 | 2018 | 11 | 0.140 |
Why?
|
| Remission Induction | 2 | 2015 | 149 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 23 | 0.130 |
Why?
|
| Risk Factors | 3 | 2017 | 5466 | 0.130 |
Why?
|
| Milk Proteins | 1 | 1997 | 45 | 0.130 |
Why?
|
| Caseins | 1 | 1997 | 42 | 0.130 |
Why?
|
| Pancreas, Artificial | 1 | 2016 | 2 | 0.130 |
Why?
|
| Milk | 1 | 1997 | 47 | 0.130 |
Why?
|
| Insulin Infusion Systems | 1 | 2016 | 10 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 36 | 0.120 |
Why?
|
| Hormones | 1 | 2016 | 62 | 0.120 |
Why?
|
| Physician Assistants | 1 | 2016 | 40 | 0.120 |
Why?
|
| Pregnancy | 2 | 2015 | 2393 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 206 | 0.120 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 122 | 0.110 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 10 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2018 | 398 | 0.100 |
Why?
|
| Adult | 7 | 2026 | 17511 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1376 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2015 | 5820 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 267 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2015 | 199 | 0.100 |
Why?
|
| Diet | 1 | 1997 | 536 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 94 | 0.100 |
Why?
|
| Middle Aged | 7 | 2026 | 18439 | 0.100 |
Why?
|
| Laboratories | 1 | 2013 | 27 | 0.100 |
Why?
|
| Calibration | 1 | 2013 | 69 | 0.100 |
Why?
|
| Bias | 1 | 2013 | 117 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 225 | 0.090 |
Why?
|
| Capillaries | 1 | 2012 | 35 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2026 | 6948 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 50 | 0.090 |
Why?
|
| Ergolines | 1 | 2012 | 1 | 0.090 |
Why?
|
| Prolactinoma | 1 | 2012 | 4 | 0.090 |
Why?
|
| Coronary Aneurysm | 1 | 2012 | 7 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2012 | 21 | 0.090 |
Why?
|
| Coronary Vasospasm | 1 | 2012 | 11 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 113 | 0.090 |
Why?
|
| Comorbidity | 1 | 2015 | 1120 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 38 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 159 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2015 | 900 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 143 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2016 | 725 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.080 |
Why?
|
| Aged | 3 | 2026 | 15089 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 1172 | 0.080 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 142 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1042 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 195 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2011 | 415 | 0.070 |
Why?
|
| Biomarkers | 2 | 2011 | 1487 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5656 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2026 | 69 | 0.060 |
Why?
|
| Propensity Score | 1 | 2026 | 192 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2024 | 206 | 0.050 |
Why?
|
| Text Messaging | 1 | 2024 | 98 | 0.050 |
Why?
|
| Rats, Inbred BB | 3 | 1997 | 134 | 0.050 |
Why?
|
| Self Care | 1 | 2024 | 218 | 0.050 |
Why?
|
| Health Behavior | 1 | 2024 | 485 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1026 | 0.040 |
Why?
|
| Telemedicine | 1 | 2026 | 376 | 0.040 |
Why?
|
| Inpatients | 1 | 2003 | 322 | 0.040 |
Why?
|
| Rats | 3 | 1997 | 1996 | 0.040 |
Why?
|
| Serum Albumin | 1 | 1997 | 47 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2018 | 58 | 0.030 |
Why?
|
| Bionics | 1 | 2016 | 3 | 0.030 |
Why?
|
| ADP Ribose Transferases | 1 | 1997 | 62 | 0.030 |
Why?
|
| Cattle | 1 | 1997 | 320 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 163 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 111 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 169 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 1996 | 127 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1996 | 83 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 4855 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 1996 | 286 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 83 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 1996 | 576 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 662 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 491 | 0.020 |
Why?
|
| Incidence | 1 | 1997 | 1432 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2014 | 181 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 181 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1997 | 2326 | 0.020 |
Why?
|
| United States | 1 | 2026 | 8166 | 0.020 |
Why?
|
| Adiponectin | 1 | 2012 | 37 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 486 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 77 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2012 | 35 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 1010 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 212 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 460 | 0.020 |
Why?
|
| Animals | 4 | 2014 | 21459 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 107 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 775 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 664 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2496 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1116 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3500 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 3777 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3162 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2003 | 57 | 0.010 |
Why?
|
| Connecticut | 1 | 2003 | 90 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 67 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 2003 | 73 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6350 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 484 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 11173 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 1997 | 38 | 0.010 |
Why?
|
| Isoantigens | 1 | 1997 | 72 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1997 | 111 | 0.010 |
Why?
|
| Thyroiditis | 1 | 1996 | 11 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 169 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 241 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 754 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 1331 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1979 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 1580 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 1633 | 0.000 |
Why?
|